• 佩雷拉谈冲突:足球比赛不是歌剧 不需要安静 2019-10-14
  • 日本新干线发生撞人事故 司机听到异响却未上报 2019-10-14
  • 张建龙:推动增绿增收协调发展 治沙治穷良性互动 2019-10-06
  • 看了许魏洲的演唱会服装才知道他时尚资源有多少 2019-10-03
  • 具体到这件事情,起因如没有特别的原因,那就是车主不想交停车费。收费员的责任最多是态度不好而已。因为收费员不可能冒着丢饭碗的风险与车主死磕,而车主倒可能因为自己的 2019-10-01
  • 先生们,当年潘大也不是一个人。 2019-09-27
  • 专访香港演员陈钰芸:女版李小龙 用武术演绎精彩人生 2019-09-27
  • 教育--北京频道--人民网 2019-09-25
  • 习近平两会期间谈社会主义核心价值观 2019-09-25
  • 【大家谈】让实干成为党员干部的标配 2019-09-24
  • 宜春通报7起作风问题典型案例 2019-09-23
  • 【聚焦军博会】216个代表团2037个项目将亮相军博会 11大军工集团全部参展 2019-09-23
  • 日本无人咖啡店开业 机器人提供周到服务 2019-09-11
  • 当端午节遇上父亲节 和爸爸一起去哪玩最好? 2019-09-11
  • 赵丽颖王子文谁赢?想靠帽子加分别错过这3个小心机! 2019-09-09
  • 客服热线:400-901-9800          客服QQ:4009019800          技术答疑   技术支持   质量反馈   人才招聘   联系我们
    首页 > 产品中心 > 一抗 > 产品信息
    Rabbit Anti-AKT1+2+3 antibody (bs-6951R)
    ~~~Bioss促销~~~
    订购热线:400-901-9800
    订购邮箱:[email protected]
    订购传真:010-58129612
    技术支持:[email protected]
    说明书: 50ul  100ul  200ul
    20ul/480.00元
    50ul/880.00元
    100ul/1580.00元
    200ul/2480.00元
    大包装/询价

    产品编号 bs-6951R
    英文名称 AKT1+2+3
    中文名称 蛋白激酶AKT1,2,3抗体
    别    名 pan-AKT; pan AKT; AKT1 + AKT2 + AKT3; AKT1+AKT2+AKT3; AKT1/AKT2/AKT3; AKT1/2/3; AKT 1; AKT; AKT1; AKT-1; AKT1_HUMAN; AKT 2; AKT2; AKT-2; AKT2_HUMAN; AKT 3; AKT3; AKT-3; AKT3_HUMAN; C AKT; cAKT; MGC9965; MGC99656; Oncogene AKT1; PKB; PKB alpha; PKB-ALPHA; PKB beta; PKB gamma; PRKBA; Protein Kinase B Alpha; Protein kinase B; Proto-oncogene c-Akt; RAC Alpha; RAC alpha serine/threonine protein kinase; RAC; RAC PK Alpha; Rac protein kinase alpha; RAC Serine/Threonine Protein Kinase; RAC-alpha serine/threonine-protein kinase; RAC-PK-alpha; v akt murine thymoma viral oncogene homolog 1; vAKT Murine Thymoma Viral Oncogene Homolog 1.  
    研究领域 肿瘤  细胞生物  信号转导  细胞凋亡  转录调节因子  激酶和磷酸酶  
    抗体来源 Rabbit
    克隆类型 Polyclonal
    交叉反应 Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Rabbit, Sheep, 
    产品应用 WB=1:500-2000 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1μg/Test ICC=1:100-500 IF=1:100-500 (石蜡切片需做抗原修复)
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
    分 子 量 56kDa
    细胞定位 细胞浆 细胞膜 
    性    状 Lyophilized or Liquid
    浓    度 1mg/ml
    免 疫 原 KLH conjugated synthetic peptide derived from human AKT1/2/3:401-480/480 
    亚    型 IgG
    纯化方法 affinity purified by Protein A
    储 存 液 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
    PubMed PubMed
    产品介绍 AKT, also known as protein kinase B (PKB), is a 57 kDa serine/threonine protein kinase. There are three mammalian isoforms of Akt: AKT1 (PKB alpha), AKT2 (PKB beta) and AKT3 (PKB gamma) with AKT2 and AKT3 being approximately 82% identical with the AKT1 isoform. Each isoform has a pleckstrin homology (PH)domain, a kinase domain and a carboxy terminal regulatory domain. AKT was originally cloned from the retrovirus AKT8, and is a key regulator of many signal transduction pathways. Its tight control over cell proliferation and cell viability are manifold; overexpression or inappropriate activation of AKT has been seen in many types of cancer. AKT mediates many of the downstream events of phosphatidylinositol 3 kinase (a lipid kinase activated by growth factors, cytokines and insulin). PI3 kinase recruits AKT to the membrane, where it is activated by PDK1 phosphorylation. Once phosphorylated, AKT dissociates from the membrane and phosphorylates targets in the cytoplasm and the cell nucleus.

    Function:
    IGF-1 leads to the activation of AKT3, which may play a role in regulating cell survival. Capable of phosphorylating several known proteins. Truncated isoform 2/PKB gamma 1 without the second serine phosphorylation site could still be stimulated but to a lesser extent.

    Subunit:
    Interacts (via the C-terminus) with CCDC88A (via its C-terminus). Interacts with GRB10; the interaction leads to GRB10 phosphorylation thus promoting YWHAE-binding. Interacts with AGAP2 (isoform 2/PIKE-A); the interaction occurs in the presence of guanine nucleotides. Interacts with AKTIP. Interacts (via PH domain) with MTCP1, TCL1A AND TCL1B. Interacts with CDKN1B; the interaction phosphorylates CDKN1B promoting 14-3-3 binding and cell-cycle progression. Interacts with MAP3K5 and TRAF6. Interacts with BAD, PPP2R5B, STK3 and STK4. Interacts (via PH domain) with SIRT1. Interacts with SRPK2 in a phosphorylation-dependent manner. Interacts with RAF1. Interacts with TRIM13; the interaction ubiquitinates AKT1 leading to its proteasomal degradation. Interacts with TNK2 and CLK2. Interacts (via the C-terminus) with THEM4 (via its C-terminus). Interacts with and phosphorylated by PDPK1.

    Subcellular Location:
    Cytoplasm. Nucleus. Cell membrane. Note=Nucleus after activation by integrin-linked protein kinase 1 (ILK1). Nuclear translocation is enhanced by interaction with TCL1A. Phosphorylation on Tyr-176 by TNK2 results in its localization to the cell membrane where it is targeted for further phosphorylations on Thr-308 and Ser-473 leading to its activation and the activated form translocates to the nucleus.

    Tissue Specificity:
    Expressed in prostate cancer and levels increase from the normal to the malignant state (at protein level). Expressed in all human cell types so far analyzed. The Tyr-176 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e. normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages.

    Post-translational modifications:
    O-GlcNAcylation at Thr-305 and Thr-312 inhibits activating phosphorylation at Thr-308 via disrupting the interaction between AKT1 and PDPK1. O-GlcNAcylation at Ser-473 also probably interferes with phosphorylation at this site.
    Phosphorylation on Thr-308, Ser-473 and Tyr-474 is required for full activity. Activated TNK2 phosphorylates it on Tyr-176 resulting in its binding to the anionic plasma membrane phospholipid PA. This phosphorylated form localizes to the cell membrane, where it is targeted by PDPK1 and PDPK2 for further phosphorylations on Thr-308 and Ser-473 leading to its activation. Ser-473 phosphorylation by mTORC2 favors Thr-308 phosphorylation by PDPK1. Ser-473 phosphorylation is enhanced by interaction with AGAP2 isoform 2 (PIKE-A). Ser-473 phosphorylation is enhanced in focal cortical dysplasias with Taylor-type balloon cells. Ser-473 phosphorylation is enhanced by signaling through activated FLT3. Dephosphorylated at Thr-308 and Ser-473 by PP2A phosphatase. The phosphorylated form of PPP2R5B is required for bridging AKT1 with PP2A phosphatase.
    Ubiquitinated via 'Lys-48'-linked polyubiquitination by ZNRF1, leading to its degradation by the proteasome. Ubiquitinated; undergoes both 'Lys-48'- and 'Lys-63'-linked polyubiquitination. TRAF6-induced 'Lys-63'-linked AKT1 ubiquitination is critical for phosphorylation and activation. When ubiquitinated, it translocates to the plasma membrane, where it becomes phosphorylated. When fully phosphorylated and translocated into the nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed by TTC3, leading to its degradation by the proteasome. Also ubiquitinated by TRIM13 leading to its proteasomal degradation.
    Acetylated on Lys-14 and Lys-20 by the histone acetyltransferases EP300 and KAT2B. Acetylation results in reduced phosphorylation and inhibition of activity. Deacetylated at Lys-14 and Lys-20 by SIRT1. SIRT1-mediated deacetylation relieves the inhibition.

    DISEASE:
    Defects in AKT1 are a cause of susceptibility to breast cancer (BC) [MIM:114480]. A common malignancy originating from breast epithelial tissue. Breast neoplasms can be distinguished by their histologic pattern. Invasive ductal carcinoma is by far the most common type.
    Breast cancer is etiologically and genetically heterogeneous. Important genetic factors have been indicated by familial occurrence and bilateral involvement. Mutations at more than one locus can be involved in different families or even in the same case.
    Defects in AKT1 are associated with colorectal cancer (CRC) [MIM:114500].
    Note=Genetic variations in AKT1 may play a role in susceptibility to ovarian cancer.
    Defects in AKT1 are a cause of Proteus syndrome (PROTEUSS) [MIM:176920]. A highly variable, severe disorder of asymmetric and disproportionate overgrowth of body parts, connective tissue nevi, epidermal nevi, dysregulated adipose tissue, and vascular malformations. Many features of Proteus syndrome overlap with other overgrowth syndromes.

    Similarity:
    Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family.
    RAC subfamily.
    Contains 1 AGC-kinase C-terminal domain.
    Contains 1 PH domain.
    Contains 1 protein kinase domain.

    SWISS:
    P31749

    Gene ID:
    207

    Database links:

    南粤风采36选7最新开奖 www.gtxm.net Entrez Gene: 207 Human

    Entrez Gene: 11651 Mouse

    Entrez Gene: 24185 Rat

    Omim: 164730 Human

    SwissProt: O57513 Chicken

    SwissProt: P31749 Human

    SwissProt: P31750 Mouse

    SwissProt: P47196 Rat

    Unigene: 525622 Human

    Unigene: 6645 Mouse

    Unigene: 11422 Rat



    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

    产品图片
    Sample:Liver (Mouse) Lysate at 40 ug
    Primary: Anti-AKT1+2+3(bs-6951R)at 1/300 dilution
    Secondary: IRDye800CW Goat Anti-RabbitIgG at 1/20000 dilution
    Predicted band size: 56kD
    Observed band size: 56kD
    Sample:
    Lung (Mouse) Lysate at 40 ug
    Placenta (Mouse) Lysate at 40 ug
    Primary: Anti-AKT1+2+3 (bs-6951R) at 1/300 dilution
    Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
    Predicted band size: 56 kD
    Observed band size: 56 kD
    Sample:
    Liver (Mouse) Lysate at 40 ug
    Lung (Mouse) Lysate at 40 ug
    Primary: Anti- AKT1+2+3 (bs-6951R) at 1/1000 dilution
    Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
    Predicted band size: 56 kD
    Observed band size: 56 kD
    Sample:
    Heart (Mouse) Lysate at 40 ug
    Primary: Anti- AKT1+2+3 (bs-6951R) at 1/1000 dilution
    Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
    Predicted band size: 56 kD
    Observed band size: 56 kD
    Sample:
    heart (Mouse) Lysate at 40 ug
    Primary: Anti-AKT1+2+3 (bs-6951R) at 1/300 dilution
    Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
    Predicted band size: 56 kD
    Observed band size: 52 kD
    Sample:
    A431Cell (Human) Lysate at 30 ug
    Hela Cell(Human)Lysate at 30 ug
    Primary: Anti-AKT1+2+3(bs-6951R)at 1/300 dilution
    Secondary: IRDye800CW Goat Anti-Rabbit IgG at 1/20000 dilution
    Predicted band size: 50 kD
    Observed band size: 50 kD
    Paraformaldehyde-fixed, paraffin embedded (rat brain); Antigen retrieval by boiling in sodium citrate buffer (pH6.0) for 15min; Block endogenous peroxidase by 3% hydrogen peroxide for 20 minutes; Blocking buffer (normal goat serum) at 37°C for 30min; Antibody incubation with (AKT1+2+3) Polyclonal Antibody, Unconjugated (bs-6951R) at 1:400 overnight at 4°C, followed by a conjugated secondary (sp-0023) for 20 minutes and DAB staining.
    Tissue/cell: mouse embryo tissue; 4% Paraformaldehyde-fixed and paraffin-embedded;
    Antigen retrieval: citrate buffer ( 0.01M, pH 6.0 ), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum,C-0005) at 37℃ for 20 min;
    Incubation: Anti-AKT1+2+3 Polyclonal Antibody, Unconjugated(bs-6951R) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody(SP-0023) and DAB(C-0010) staining
    Tissue/cell: rat brain tissue; 4% Paraformaldehyde-fixed and paraffin-embedded;
    Antigen retrieval: citrate buffer ( 0.01M, pH 6.0 ), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum,C-0005) at 37℃ for 20 min;
    Incubation: Anti-AKT1+2+3 Polyclonal Antibody, Unconjugated(bs-6951R) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody(SP-0023) and DAB(C-0010) staining
    Tissue/cell: Mouse embryos tissue; 4% Paraformaldehyde-fixed and paraffin-embedded;
    Antigen retrieval: citrate buffer ( 0.01M, pH 6.0 ), Boiling bathing for 15min; Block endogenous peroxidase by 3% Hydrogen peroxide for 30min; Blocking buffer (normal goat serum,C-0005) at 37℃ for 20 min;
    Incubation: Anti-AKT1 + 2 + 3 Polyclonal Antibody, Unconjugated(bs-6951R) 1:200, overnight at 4°C, followed by conjugation to the secondary antibody(SP-0023) and DAB(C-0010) staining
    Blank control(blue): TM4 cells(fixed with 2% paraformaldehyde (10 min) , then permeabilized with 90% ice-cold methanol for 30 min on ice).
    Primary Antibody:Rabbit Anti-AKT1+2+3 antibody(bs-6951R), Dilution: 1μg in 100 μL 1X PBS containing 0.5% BSA;
    Isotype Control Antibody: Rabbit IgG(orange) ,used under the same conditions );
    Secondary Antibody: Goat anti-rabbit IgG-PE(white blue), Dilution: 1:200 in 1 X PBS containing 0.5% BSA.
    版权所有 2016-2020 南粤风采36选7最新开奖 www.gtxm.net 北京博奥森生物技术有限公司 京ICP备05066980号 京公网安备110107000727号
    通过国际质量管理体系ISO9001:2008 GB/T19001-2008认证    编号:00115Q211807R1M/1100
  • 佩雷拉谈冲突:足球比赛不是歌剧 不需要安静 2019-10-14
  • 日本新干线发生撞人事故 司机听到异响却未上报 2019-10-14
  • 张建龙:推动增绿增收协调发展 治沙治穷良性互动 2019-10-06
  • 看了许魏洲的演唱会服装才知道他时尚资源有多少 2019-10-03
  • 具体到这件事情,起因如没有特别的原因,那就是车主不想交停车费。收费员的责任最多是态度不好而已。因为收费员不可能冒着丢饭碗的风险与车主死磕,而车主倒可能因为自己的 2019-10-01
  • 先生们,当年潘大也不是一个人。 2019-09-27
  • 专访香港演员陈钰芸:女版李小龙 用武术演绎精彩人生 2019-09-27
  • 教育--北京频道--人民网 2019-09-25
  • 习近平两会期间谈社会主义核心价值观 2019-09-25
  • 【大家谈】让实干成为党员干部的标配 2019-09-24
  • 宜春通报7起作风问题典型案例 2019-09-23
  • 【聚焦军博会】216个代表团2037个项目将亮相军博会 11大军工集团全部参展 2019-09-23
  • 日本无人咖啡店开业 机器人提供周到服务 2019-09-11
  • 当端午节遇上父亲节 和爸爸一起去哪玩最好? 2019-09-11
  • 赵丽颖王子文谁赢?想靠帽子加分别错过这3个小心机! 2019-09-09
  • 分分彩计划软件哪个好 公式规律交流群网址 江西体彩多乐彩基本走势图 全天幸运赛马计划开奖 台湾五分彩开奖号码查询 私人牛牛影音 开心娱乐平台注册 组选560前后关系 广东快中彩玩法 澳门赌场玩什么最容易 彩票大奖中奖方法 贵州11选5技巧稳赚 怎样选双色球中奖率高 重庆快乐十分走势图一定牛 广东省福利彩票中心